UPDATE 2-FDA orders Jash to stop sales of four tobacco products

Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday it has ordered Jash International to stop selling four tobacco products that it said do not meet regulatory standards.

The agency gave Jash multiple opportunities to provide the FDA with the information it required to determine whether its Sutra Bidis cigarettes were in compliance with the law, said Mitch Zeller, head of the FDA's tobacco division.

Jash's failure to provide the information meant the FDA determined the company's products to be misbranded and adulterated, Zeller said in an interview.